カテゴリー： QYResearch, 世界

世界の三価インフルエンザワクチン産業：成長傾向・競合分析2019-2025

【英語タイトル】Global Trivalent Flu Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

QYResearchが出版した調査資料（DATA909X02458）・商品コード：DATA909X02458
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：112
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥725,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,087,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,450,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートでは、世界の三価インフルエンザワクチン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。三価インフルエンザワクチンの種類別には、筋肉内注射、点鼻薬、皮内注射に、用途別には、病院、クリニック、公衆衛生局、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・三価インフルエンザワクチンの種類別市場規模：筋肉内注射、点鼻薬、皮内注射
・三価インフルエンザワクチンの用途別市場規模：病院、クリニック、公衆衛生局、その他
・三価インフルエンザワクチンの地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール：Sanofi Pasteur、AstraZeneca、CSL、Abbott、GlaxoSmithKline、Serum Institute of India
・市場規模予測2019-2025：生産量
・市場規模予測2019-2025：消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...
【レポートの概要】

In 2018, the global Trivalent Flu Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Trivalent Flu Vaccine.
This study researches the market size of Trivalent Flu Vaccine, presents the global Trivalent Flu Vaccine sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Trivalent Flu Vaccine in key regions like North America, Europe, China and Japan, presents sales, revenue, market share, growth rate of Trivalent Flu Vaccine for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
AstraZeneca
CSL
Abbott
GlaxoSmithKline
Serum Institute of India
…

Market Segment by Product Type
Intramuscular Injection
Nasal Spray
Intradermal Shot

Market Segment by Application
Hospital
Clinic
Public Health Agency
Other

Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Trivalent Flu Vaccine status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Trivalent Flu Vaccine manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Trivalent Flu Vaccine are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Trivalent Flu Vaccine Market Size Growth Rate by Type
1.3.2 Intramuscular Injection
1.3.3 Nasal Spray
1.3.4 Intradermal Shot
1.4 Market Segment by Application
1.4.1 Global Trivalent Flu Vaccine Market Share by Application (2019-2025)
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Public Health Agency
1.4.5 Other
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Trivalent Flu Vaccine Market Size
2.1.1 Global Trivalent Flu Vaccine Revenue 2014-2025
2.1.2 Global Trivalent Flu Vaccine Sales 2014-2025
2.2 Trivalent Flu Vaccine Growth Rate by Regions
2.2.1 Global Trivalent Flu Vaccine Sales by Regions 2014-2019
2.2.2 Global Trivalent Flu Vaccine Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Trivalent Flu Vaccine Sales by Manufacturers
3.1.1 Trivalent Flu Vaccine Sales by Manufacturers 2014-2019
3.1.2 Trivalent Flu Vaccine Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Trivalent Flu Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Trivalent Flu Vaccine Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Trivalent Flu Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 Trivalent Flu Vaccine Price by Manufacturers
3.4 Key Manufacturers Trivalent Flu Vaccine Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Trivalent Flu Vaccine Market
3.6 Key Manufacturers Trivalent Flu Vaccine Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Intramuscular Injection Sales and Revenue (2014-2019)
4.1.2 Nasal Spray Sales and Revenue (2014-2019)
4.1.3 Intradermal Shot Sales and Revenue (2014-2019)
4.2 Global Trivalent Flu Vaccine Sales Market Share by Type
4.3 Global Trivalent Flu Vaccine Revenue Market Share by Type
4.4 Trivalent Flu Vaccine Price by Type

5 Market Size by Application
5.1 Overview
5.1 Global Trivalent Flu Vaccine Sales by Application

6 North America
6.1 North America Trivalent Flu Vaccine Breakdown Data by Company
6.2 North America Trivalent Flu Vaccine Breakdown Data by Type
6.3 North America Trivalent Flu Vaccine Breakdown Data by Application
6.4 North America Trivalent Flu Vaccine Breakdown Data by Countries
6.4.1 North America Trivalent Flu Vaccine Sales by Countries
6.4.2 North America Trivalent Flu Vaccine Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Trivalent Flu Vaccine Breakdown Data by Company
7.2 Europe Trivalent Flu Vaccine Breakdown Data by Type
7.3 Europe Trivalent Flu Vaccine Breakdown Data by Application
7.4 Europe Trivalent Flu Vaccine Breakdown Data by Countries
7.4.1 Europe Trivalent Flu Vaccine Sales by Countries
7.4.2 Europe Trivalent Flu Vaccine Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Trivalent Flu Vaccine Breakdown Data by Company
8.2 Asia Pacific Trivalent Flu Vaccine Breakdown Data by Type
8.3 Asia Pacific Trivalent Flu Vaccine Breakdown Data by Application
8.4 Asia Pacific Trivalent Flu Vaccine Breakdown Data by Regions
8.4.1 Asia Pacific Trivalent Flu Vaccine Sales by Countries
8.4.2 Asia Pacific Trivalent Flu Vaccine Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Trivalent Flu Vaccine Breakdown Data by Company
9.2 Central & South America Trivalent Flu Vaccine Breakdown Data by Type
9.3 Central & South America Trivalent Flu Vaccine Breakdown Data by Application
9.4 Central & South America Trivalent Flu Vaccine Breakdown Data by Countries
9.4.1 Central & South America Trivalent Flu Vaccine Sales by Countries
9.4.2 Central & South America Trivalent Flu Vaccine Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Trivalent Flu Vaccine Breakdown Data by Type
10.2 Middle East and Africa Trivalent Flu Vaccine Breakdown Data by Application
10.3 Middle East and Africa Trivalent Flu Vaccine Breakdown Data by Countries
10.3.1 Middle East and Africa Trivalent Flu Vaccine Sales by Countries
10.3.2 Middle East and Africa Trivalent Flu Vaccine Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa

11 Company Profiles
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Trivalent Flu Vaccine
11.1.4 Trivalent Flu Vaccine Product Introduction
11.1.5 Sanofi Pasteur Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Trivalent Flu Vaccine
11.2.4 Trivalent Flu Vaccine Product Introduction
11.2.5 AstraZeneca Recent Development
11.3 CSL
11.3.1 CSL Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Trivalent Flu Vaccine
11.3.4 Trivalent Flu Vaccine Product Introduction
11.3.5 CSL Recent Development
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Trivalent Flu Vaccine
11.4.4 Trivalent Flu Vaccine Product Introduction
11.4.5 Abbott Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Trivalent Flu Vaccine
11.5.4 Trivalent Flu Vaccine Product Introduction
11.5.5 GlaxoSmithKline Recent Development
11.6 Serum Institute of India
11.6.1 Serum Institute of India Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Trivalent Flu Vaccine
11.6.4 Trivalent Flu Vaccine Product Introduction
11.6.5 Serum Institute of India Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Trivalent Flu Vaccine Sales Channels
12.2.2 Trivalent Flu Vaccine Distributors
12.3 Trivalent Flu Vaccine Customers

13 Market Forecast
13.1 Global Trivalent Flu Vaccine Sales and Revenue Forecast 2019-2025
13.2 Global Trivalent Flu Vaccine Sales Forecast by Type
13.3 Global Trivalent Flu Vaccine Sales Forecast by Application
13.4 Trivalent Flu Vaccine Forecast by Regions
13.4.1 Global Trivalent Flu Vaccine Sales Forecast by Regions 2019-2025
13.4.2 Global Trivalent Flu Vaccine Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Trivalent Flu Vaccine Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Trivalent Flu Vaccine Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Trivalent Flu Vaccine Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Trivalent Flu Vaccine Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Trivalent Flu Vaccine Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Trivalent Flu Vaccine Product Picture
Table Trivalent Flu Vaccine Key Market Segments
Table Major Manufacturers Trivalent Flu Vaccine Covered in This Report
Table Global Trivalent Flu Vaccine Market Size Growth Rate by Type 2019-2025 (K Doses) & (Million US$)
Figure Global Trivalent Flu Vaccine Sales Market Shar by Type 2014-2025
Figure Intramuscular Injection Figures
Table Major Manufacturers of Intramuscular Injection
Figure Nasal Spray Figures
Table Major Manufacturers of Nasal Spray
Figure Intradermal Shot Figures
Table Major Manufacturers of Intradermal Shot
Table Global Trivalent Flu Vaccine Market Share by Application 2019-2025 (K Doses)
Figure Hospital Use Case
Figure Clinic Use Case
Figure Public Health Agency Use Case
Figure Other Use Case
Figure Trivalent Flu Vaccine Report Years Considered
Figure Global Trivalent Flu Vaccine Market Size 2014-2025 (Million US$)
Figure Global Trivalent Flu Vaccine Sales 2014-2019 (K Doses)
Table Global Trivalent Flu Vaccine Market Size by Regions 2014-2019 (K Doses) & (Million US$)
Table Global Trivalent Flu Vaccine Sales by Regions 2014-2019 (K Doses)
Table Global Trivalent Flu Vaccine Sales Market Share by Regions 2014-2019
Figure Global Trivalent Flu Vaccine Sales Market Share by Regions 2014-2019
Figure Global Trivalent Flu Vaccine Sales Market Share by Regions in 2018
Table Global Trivalent Flu Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global Trivalent Flu Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Trivalent Flu Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Trivalent Flu Vaccine Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Trivalent Flu Vaccine Sales by Manufacturers (2014-2019) (K Doses)
Table Global Trivalent Flu Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global Trivalent Flu Vaccine Sales Share by Manufacturers in 2018
Table Trivalent Flu Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table Trivalent Flu Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Trivalent Flu Vaccine Value Share by Manufacturers in 2018
Table Global Trivalent Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Trivalent Flu Vaccine Price (2014-2019) (USD/Dose)
Table Key Manufacturers Trivalent Flu Vaccine Plants/Factories Distribution
Table Key Manufacturers Trivalent Flu Vaccine Area Served
Table Date of Key Manufacturers Enter into Trivalent Flu Vaccine Market
Table Key Manufacturers Trivalent Flu Vaccine Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Intramuscular Injection Sales an目录输出!D Revenue (2014-2019) (K Doses) & (Million US$)
Table Global Nasal Spray Sales an目录输出!D Revenue (2014-2019) (K Doses) & (Million US$)
Table Global Intradermal Shot Sales an目录输出!D Revenue (2014-2019) (K Doses) & (Million US$)
Table Global Trivalent Flu Vaccine Sales by Type (2014-2019) (K Doses)
Table Global Trivalent Flu Vaccine Sales Share by Type (2014-2019)
Figure Global Trivalent Flu Vaccine Sales Market Share by Type (2014-2019)
Figure Global Trivalent Flu Vaccine Sales Market Share by Type in 2018
Table Global Trivalent Flu Vaccine Revenue by Type (2014-2019) (Million US$)
Table Global Trivalent Flu Vaccine Revenue Share by Type (2014-2019)
Figure Global Trivalent Flu Vaccine Revenue Market Share by Type (2014-2019)
Figure Global Trivalent Flu Vaccine Revenue Market Share by Type in 2018
Table Trivalent Flu Vaccine Price by Type 2014-2019 (USD/Dose)
Table Global Trivalent Flu Vaccine Sales by Application (2014-2019) (K Doses)
Table Global Trivalent Flu Vaccine Sales Share by Application (2014-2019)
Figure Global Sales Trivalent Flu Vaccine Market Share by Application (2014-2019)
Figure Global Sales Trivalent Flu Vaccine Market Share by Application in 2018
Figure North America Trivalent Flu Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure North America Trivalent Flu Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Trivalent Flu Vaccine Sales by Company (2014-2019) (K Doses)
Table North America Trivalent Flu Vaccine Sales Market Share by Company (2014-2019)
Figure North America Trivalent Flu Vaccine Sales Market Share by Company in 2018
Table North America Trivalent Flu Vaccine Sales by Type (2014-2019) (K Doses)
Table North America Trivalent Flu Vaccine Sales Market Share by Type (2014-2019)
Figure North America Trivalent Flu Vaccine Market Share by Type in 2018
Table North America Trivalent Flu Vaccine Sales by Application (2014-2019) (K Doses)
Table North America Trivalent Flu Vaccine Sales Market Share by Application (2014-2019)
Figure North America Trivalent Flu Vaccine Market Share by Application in 2018
Table North America Trivalent Flu Vaccine Sales by Countries (2014-2019) (K Doses)
Table North America Trivalent Flu Vaccine Sales Market Share by Countries (2014-2019)
Figure North America Trivalent Flu Vaccine Sales Market Share by Countries in 2018
Table North America Trivalent Flu Vaccine Revenue by Countries (2014-2019) (Million US$)
Table North America Trivalent Flu Vaccine Revenue Market Share by Countries (2014-2019)
Figure North America Trivalent Flu Vaccine Revenue Market Share by Countries in 2018
Figure United States Trivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Canada Trivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Mexico Trivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Europe Trivalent Flu Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Europe Trivalent Flu Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Trivalent Flu Vaccine Sales by Company (2014-2019) (K Doses)
Table Europe Trivalent Flu Vaccine Sales Market Share by Company (2014-2019)
Figure Europe Trivalent Flu Vaccine Sales Market Share by Company in 2018
Table Europe Trivalent Flu Vaccine Sales by Type (2014-2019) (K Doses)
Table Europe Trivalent Flu Vaccine Sales Market Share by Type (2014-2019)
Figure Europe Trivalent Flu Vaccine Sales Market Share by Type in 2018
Table Europe Trivalent Flu Vaccine Sales by Application (2014-2019) (K Doses)
Table Europe Trivalent Flu Vaccine Sales Market Share by Application (2014-2019)
Figure Europe Trivalent Flu Vaccine Sales Market Share by Application in 2018
Table Europe Trivalent Flu Vaccine Sales by Countries (2014-2019) (K Doses)
Table Europe Trivalent Flu Vaccine Sales Market Share by Countries (2014-2019)
Figure Europe Trivalent Flu Vaccine Sales Market Share by Countries in 2018
Table Europe Trivalent Flu Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Europe Trivalent Flu Vaccine Revenue Market Share by Countries (2014-2019)
Figure Europe Trivalent Flu Vaccine Revenue Market Share by Countries in 2018
Figure Germany Trivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure France Trivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure UK Trivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Italy Trivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Russia Trivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Asia Pacific Trivalent Flu Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Asia Pacific Trivalent Flu Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Trivalent Flu Vaccine Sales by Regions (2014-2019) (K Doses)
Table Asia Pacific Trivalent Flu Vaccine Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Trivalent Flu Vaccine Sales Market Share by Regions in 2018
Table Asia Pacific Trivalent Flu Vaccine Sales by Type (2014-2019) (K Doses)
Table Asia Pacific Trivalent Flu Vaccine Sales Market Share by Type (2014-2019)
Figure Asia Pacific Trivalent Flu Vaccine Market Share by Type in 2018
Table Asia Pacific Trivalent Flu Vaccine Sales by Application (2014-2019) (K Doses)
Table Asia Pacific Trivalent Flu Vaccine Sales Market Share by Application (2014-2019)
Figure Asia Pacific Trivalent Flu Vaccine Market Share by Application in 2018
Table Asia Pacific Trivalent Flu Vaccine Sales by Countries (2014-2019) (K Doses)
Table Asia Pacific Trivalent Flu Vaccine Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Trivalent Flu Vaccine Sales Market Share by Regions in 2018
Table Asia Pacific Trivalent Flu Vaccine Revenue by Regions (2014-2019) (Million US$)
Table Asia Pacific Trivalent Flu Vaccine Revenue Market Share by Regions (2014-2019)
Figure Asia Pacific Trivalent Flu Vaccine Revenue Market Share by Regions in 2018
Figure China Trivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure China Trivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Trivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Japan Trivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Trivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Korea Trivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Trivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure India Trivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Trivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Australia Trivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Trivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Indonesia Trivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Trivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Malaysia Trivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Trivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Philippines Trivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Trivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Thailand Trivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Trivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Vietnam Trivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America Trivalent Flu Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Central & South America Trivalent Flu Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Trivalent Flu Vaccine Sales by Company (2014-2019) (K Doses)
Table Central & South America Trivalent Flu Vaccine Sales Market Share by Company (2014-2019)
Figure Central & South America Trivalent Flu Vaccine Sales Market Share by Company in 2018
Table Central & South America Trivalent Flu Vaccine Sales by Type (2014-2019) (K Doses)
Table Central & South America Trivalent Flu Vaccine Sales Market Share by Type (2014-2019)
Figure Central & South America Trivalent Flu Vaccine Market Share by Type in 2018
Table Central & South America Trivalent Flu Vaccine Sales by Application (2014-2019) (K Doses)
Table Central & South America Trivalent Flu Vaccine Sales Market Share by Application (2014-2019)
Figure Central & South America Trivalent Flu Vaccine Market Share by Application in 2018
Table Central & South America Trivalent Flu Vaccine Sales by Countries (2014-2019) (K Doses)
Table Central & South America Trivalent Flu Vaccine Sales Market Share by Countries (2014-2019)
Figure Central & South America Trivalent Flu Vaccine Sales Market Share by Countries in 2018
Table Central & South America Trivalent Flu Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Trivalent Flu Vaccine Revenue Market Share by Countries (2014-2019)
Figure Central & South America Trivalent Flu Vaccine Revenue Market Share by Countries in 2018
Figure Brazil Trivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Brazil Trivalent Flu Vaccine Revenue Growth Rate (2014-2019) (K Doses)
Figure Middle East and Africa Trivalent Flu Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Middle East and Africa Trivalent Flu Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Trivalent Flu Vaccine Sales by Type (2014-2019) (K Doses)
Table Middle East and Africa Trivalent Flu Vaccine Sales Market Share by Type (2014-2019)
Figure Middle East and Africa Trivalent Flu Vaccine Sales Market Share by Type in 2018
Table Middle East and Africa Trivalent Flu Vaccine Sales by Application (2014-2019) (K Doses)
Table Middle East and Africa Trivalent Flu Vaccine Sales Market Share by Application (2014-2019)
Figure Middle East and Africa Trivalent Flu Vaccine Sales Market Share by Application in 2018
Table Middle East and Africa Trivalent Flu Vaccine Sales by Countries (2014-2019) (K Doses)
Table Middle East and Africa Trivalent Flu Vaccine Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Trivalent Flu Vaccine Sales Market Share by Countries in 2018
Table Middle East and Africa Trivalent Flu Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Trivalent Flu Vaccine Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Trivalent Flu Vaccine Revenue Market Share by Countries in 2018
Figure GCC Countries Trivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure GCC Countries Trivalent Flu Vaccine Revenue Growth Rate (2014-2019) (K Doses)
Figure Egypt Trivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Egypt Trivalent Flu Vaccine Revenue Growth Rate (2014-2019) (K Doses)
Figure South Africa Trivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure South Africa Trivalent Flu Vaccine Revenue Growth Rate (2014-2019) (K Doses)
Table Sanofi Pasteur Company Details
Table Sanofi Pasteur Description and Business Overview
Table Sanofi Pasteur Trivalent Flu Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table Sanofi Pasteur Trivalent Flu Vaccine Sales Growth Rate (2014-2019)
Table Sanofi Pasteur Trivalent Flu Vaccine Sales Market Share in Global Market
Table Sanofi Pasteur Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Description and Business Overview
Table AstraZeneca Trivalent Flu Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table AstraZeneca Trivalent Flu Vaccine Sales Growth Rate (2014-2019)
Table AstraZeneca Trivalent Flu Vaccine Sales Market Share in Global Market
Table AstraZeneca Recent Development
Table CSL Company Details
Table CSL Description and Business Overview
Table CSL Trivalent Flu Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table CSL Trivalent Flu Vaccine Sales Growth Rate (2014-2019)
Table CSL Trivalent Flu Vaccine Sales Market Share in Global Market
Table CSL Recent Development
Table Abbott Company Details
Table Abbott Description and Business Overview
Table Abbott Trivalent Flu Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table Abbott Trivalent Flu Vaccine Sales Growth Rate (2014-2019)
Table Abbott Trivalent Flu Vaccine Sales Market Share in Global Market
Table Abbott Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Description and Business Overview
Table GlaxoSmithKline Trivalent Flu Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table GlaxoSmithKline Trivalent Flu Vaccine Sales Growth Rate (2014-2019)
Table GlaxoSmithKline Trivalent Flu Vaccine Sales Market Share in Global Market
Table GlaxoSmithKline Recent Development
Table Serum Institute of India Company Details
Table Serum Institute of India Description and Business Overview
Table Serum Institute of India Trivalent Flu Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table Serum Institute of India Trivalent Flu Vaccine Sales Growth Rate (2014-2019)
Table Serum Institute of India Trivalent Flu Vaccine Sales Market Share in Global Market
Table Serum Institute of India Recent Development
Figure Trivalent Flu Vaccine Value Chain
Table Trivalent Flu Vaccine Distributors List
Table Trivalent Flu Vaccine Customers List
Table Global Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses) & (Million US$)
Figure Global Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Global Trivalent Flu Vaccine Revenue Forecast 2019-2025 (Million US$)
Table Global Trivalent Flu Vaccine Sales Forecast by Type 2019-2025 (K Doses)
Figure Global Trivalent Flu Vaccine Sales Forecast by Type 2019-2025 (K Doses)
Figure Global Trivalent Flu Vaccine Sales Market Share Forecast by Type 2019-2025
Table Global Trivalent Flu Vaccine Sales Forecast by Application 2019-2025 (K Doses)
Figure Global Trivalent Flu Vaccine Sales Forecast by Application 2019-2025 (K Doses)
Figure Global Trivalent Flu Vaccine Sales Market Share Forecast by Application 2019-2025
Table Global Trivalent Flu Vaccine Sales Forecast by Regions 2019-2025 (K Doses)
Figure Global Trivalent Flu Vaccine Sales Forecast by Regions 2019-2025 (K Doses)
Figure Global Trivalent Flu Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global Trivalent Flu Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Trivalent Flu Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Trivalent Flu Vaccine Revenue Market Share Forecast by Regions 2019-2025
Table North America Trivalent Flu Vaccine Sales Forecast by Countries 2019-2025 (K Doses)
Table North America Trivalent Flu Vaccine Sales Market Share Forecast by Countries 2019-2025
Table North America Trivalent Flu Vaccine Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America Trivalent Flu Vaccine Revenue Market Share Forecast by Countries 2019-2025
Figure United States Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Canada Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Mexico Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Table Europe Trivalent Flu Vaccine Sales Forecast by Countries 2019-2025 (K Doses)
Table Europe Trivalent Flu Vaccine Sales Market Share Forecast by Countries 2019-2025
Table Europe Trivalent Flu Vaccine Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe Trivalent Flu Vaccine Revenue Market Share Forecast by Countries 2019-2025
Figure Germany Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure France Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure UK Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Italy Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Russia Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Table Asia Pacific Trivalent Flu Vaccine Sales Forecast by Regions 2019-2025 (K Doses)
Table Asia Pacific Trivalent Flu Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Asia Pacific Trivalent Flu Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Asia Pacific Trivalent Flu Vaccine Revenue Market Share Forecast by Regions 2019-2025
Figure China Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Japan Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure South Korea Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure India Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Australia Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Indonesia Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Thailand Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Malaysia Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Philippines Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Vietnam Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Table Central & South America Trivalent Flu Vaccine Sales Forecast by Countries 2019-2025 (K Doses)
Table Central & South America Trivalent Flu Vaccine Sales Market Share Forecast by Countries 2019-2025
Table Central & South America Trivalent Flu Vaccine Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America Trivalent Flu Vaccine Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Table Middle East and Africa Trivalent Flu Vaccine Sales Forecast by Regions 2019-2025 (K Doses)
Table Middle East and Africa Trivalent Flu Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa Trivalent Flu Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa Trivalent Flu Vaccine Revenue Market Share Forecast by Regions 2019-2025
Figure Turkey Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure GCC Countries Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Egypt Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure South Africa Trivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Sanofi Pasteur、AstraZeneca、CSL、Abbott、GlaxoSmithKline、Serum Institute of India

★調査レポート[世界の三価インフルエンザワクチン産業：成長傾向・競合分析2019-2025] (コード：DATA909X02458)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の三価インフルエンザワクチン産業：成長傾向・競合分析2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の魚ワクチン産業：成長傾向・競合分析2019-2025
    DATA909X00898 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界の魚ワクチン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。魚ワクチンの種類別には、不活化魚ワクチン、弱毒魚ワクチン、トキソイド魚ワクチン、複合魚ワクチン、その他に、用途別には、獣医薬局、獣医クリニック、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・魚ワクチンの種類別市場規模：不活化魚ワクチン、弱毒魚ワクチン、トキソイド魚ワクチン、複合魚ワクチン、その他 ・魚ワクチンの用途別市場規模：獣医薬局、獣医クリニック、その他 ・魚ワクチンの地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Lumic A/S、Syndel USA、PHARMAQ、CZ...Vaccination plays a vital role in large scale fish farming production. Vaccination of fish provides protection against common viral or bacterial diseases. Fish vaccines can radially reduce the mortality rate and increase the production rate. Fish vaccines is the best method to enhance the survival rate and increase the profitability of the aquaculture business. Fish vaccines is generally given to species such as Salmon, Sea Bass and Cod. Fish vaccines is widely used method in aquaculture.In 2018, the global Fish Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR...
  • 世界の四価インフルエンザワクチン産業：成長傾向・競合分析2019-2025
    DATA909X01920 / QYResearch / 2019年11月25日 / ※本調査レポートでは、世界の四価インフルエンザワクチン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。四価インフルエンザワクチンの種類別には、筋肉内注射、点鼻薬、皮内注射に、用途別には、病院、診療所、公衆衛生局、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・四価インフルエンザワクチンの種類別市場規模：筋肉内注射、点鼻薬、皮内注射 ・四価インフルエンザワクチンの用途別市場規模：病院、診療所、公衆衛生局、その他 ・四価インフルエンザワクチンの地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Sanofi Pasteur、AstraZeneca、CSL、Abbott、GlaxoSmithKline ・市場規模予測2019-2025：生産量...In 2018, the global Quadrivalent Flu Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Quadrivalent Flu Vaccine. This study researches the market size of Quadrivalent Flu Vaccine, presents the global Quadrivalent Flu Vaccine sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025. This report focuses on the key...
  • 世界の遺伝子ワクチン産業：成長傾向・競合分析2019-2025
    DATA909X01016 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界の遺伝子ワクチン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。遺伝子ワクチンの種類別には、組換えタンパク質ワクチン、遺伝子ベースワクチンに、用途別には、人間、動物に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・遺伝子ワクチンの種類別市場規模：組換えタンパク質ワクチン、遺伝子ベースワクチン ・遺伝子ワクチンの用途別市場規模：人間、動物 ・遺伝子ワクチンの地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Merck、GSK、Sanofi、Zoties、Elanco、Boehringer-Ingelheim、Indian Immunologicals、Plumbline Life...Gene vaccine refers to DNA vaccine, the gene encoding exogenous antigen is inserted into the plasmid containing eukaryotic expression system, and then the plasmid is directly introduced into the human or animal body, allowing it to express antigen protein in host cells and induce the immune response of the body.In 2018, the global Genetic Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the...
  • 世界の動物用生物学的ワクチン産業：成長傾向・競合分析2019-2025
    DATA909X00116 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界の動物用生物学的ワクチン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。動物用生物学的ワクチンの種類別には、経口、皮下、筋肉内、その他に、用途別には、ブタ、家禽、家畜、愛玩動物、養殖に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・動物用生物学的ワクチンの種類別市場規模：経口、皮下、筋肉内、その他 ・動物用生物学的ワクチンの用途別市場規模：ブタ、家禽、家畜、愛玩動物、養殖 ・動物用生物学的ワクチンの地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Merck、Zoetis、Merial/Sanofi、Boehringer Ingelheim、Ceva、CAHIC、HVRI、Ringpu Biology、Yebio、DHN、WINSUN、Elanco/Eli...In 2018, the global Animal Biological Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Animal Biological Vaccine. This study researches the market size of Animal Biological Vaccine, presents the global Animal Biological Vaccine sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025. This report focuses on the key...
  • 世界の組換えタンパク質ワクチン産業：成長傾向・競合分析2019-2025
    DATA909X01954 / QYResearch / 2019年11月25日 / ※本調査レポートでは、世界の組換えタンパク質ワクチン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。組換えタンパク質ワクチンの種類別には、細菌細胞培養、哺乳類細胞培養に、用途別には、人間、動物に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・組換えタンパク質ワクチンの種類別市場規模：細菌細胞培養、哺乳類細胞培養 ・組換えタンパク質ワクチンの用途別市場規模：人間、動物 ・組換えタンパク質ワクチンの地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Merck、GSK、Sanofi、Zoties、Elanco、Boehringer-Ingelheim、Indian Immunologicals、Plumbline Life...Recombinant Protein Vaccine refers to the vaccines manufactured using recombinant DNA technologyIn 2018, the global Recombinant Protein Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Recombinant Protein Vaccine. This study researches the market size of Recombinant Protein Vaccine, presents the global Recombinant Protein Vaccine sales and revenue by companies, regions, type and application, history breakdown data from 2014 to...
  • 世界の鼻スプレーイ型ンフルエンザワクチン産業：成長傾向・競合分析2019-2025
    DATA909X01574 / QYResearch / 2019年11月25日 / ※本調査レポートでは、世界の鼻スプレーイ型ンフルエンザワクチン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。鼻スプレーイ型ンフルエンザワクチンの種類別には、三価インフルエンザワクチン、四価インフルエンザワクチに、用途別には、病院、クリニック、公衆衛生局、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・鼻スプレーイ型ンフルエンザワクチンの種類別市場規模：三価インフルエンザワクチン、四価インフルエンザワクチ ・鼻スプレーイ型ンフルエンザワクチンの用途別市場規模：病院、クリニック、公衆衛生局、その他 ・鼻スプレーイ型ンフルエンザワクチンの地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Sanofi Pasteur、AstraZeneca、CSL、Abbott、GlaxoSmithKline、Serum Institute...In 2018, the global Nasal Spray Flu Vaccines market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Nasal Spray Flu Vaccines. This study researches the market size of Nasal Spray Flu Vaccines, presents the global Nasal Spray Flu Vaccines sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025. This report...
  • 世界のジャキニブ産業：成長傾向・競合分析2019-2025
    DATA909X01274 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界のジャキニブ市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。ジャキニブの種類別には、自己免疫疾患、腫瘍学に、用途別には、クリニック、病院に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・ジャキニブの種類別市場規模：自己免疫疾患、腫瘍学 ・ジャキニブの用途別市場規模：クリニック、病院 ・ジャキニブの地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Astellas Pharma, Inc.、Eli...Jakinibs are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.In 2018, the global Jakinibs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Jakinibs. This study researches the market size of Jakinibs, presents the global Jakinibs sales...
  • 世界のMEK阻害剤産業：成長傾向・競合分析2019-2025
    DATA909X01476 / QYResearch / 2019年11月25日 / ※本調査レポートでは、世界のMEK阻害剤市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。MEK阻害剤の種類別には、メキニスト、コテリック、メクトビに、用途別には、NSCLC、がんに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・MEK阻害剤の種類別市場規模：メキニスト、コテリック、メクトビ ・MEK阻害剤の用途別市場規模：NSCLC、がん ・MEK阻害剤の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：AstraZeneca Plc、F. Hoffmann-La...A MEK inhibitor is a chemical or drug that inhibits the mitogen-activated protein kinase kinase enzymes MEK1 and/or MEK2.In 2018, the global MEK Inhibitors market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for MEK Inhibitors. This study researches the market size of MEK Inhibitors, presents the global MEK Inhibitors sales and revenue by companies, regions, type and application, history breakdown data from 2014...

    • ◆H&Iグローバルリサーチのお客様（例）◆